| PTLE 0.282 51.53% | SOXS 3.65 11.56% | MSPR 0.664 27.57% | SCNX 0.8182 15.35% | NVDA 198.69 -3.96% | SQQQ 13.79 6.16% | ORIS 0.1603 -0.12% | BYND 1.33 -4.32% | PFE 24.3 -1.46% | HTZ 6.73 36.23% | PLTR 190.74 -7.94% | TSLL 20.34 -10.16% | ETHA 24.28 -10.37% | ASST 1.25 -1.57% | IBIT 57.18 -5.53% | GRAB 5.785 -4.70% | INTC 37.03 -6.25% | PLUG 2.52 -8.36% | ONDS 5.96 -3.09% | OPEN 6.92 -8.83% | CHR 0.136 8.11% | FGL 0.5165 26.94% | DNN 2.74 -6.00% | TSLA 444.26 -5.15% | WTO 0.0497 -6.23% | CAPT 0.6615 31.77% | NFE 1.35 14.41% | SOXL 42.8 -11.90% | BITF 3.84 -6.57% | ETHD 5.26 20.92% | T 24.44 -0.37% | EPWK 0.0748 3.60% | F 12.79 -1.69% | SPY 675.24 -1.19% | SOFI 29.37 -4.11% | KVUE 15.97 -1.05% | ACHR 9.56 -8.25% | CIFR 22.51 -1.10% | QQQ 619.25 -2.03% | HIMS 42.79 -3.60% | GPUS 0.3494 -7.03% | TQQQ 111.08 -6.12% | LQD 110.68 0.14% | BTBT 3.18 -7.02% | AAL 12.65 -5.17% | TZA 8.21 5.26% | BURU 0.29 -7.91% | NCLH 18.79 -15.28% | RGTI 35.18 -10.07% | BTG 4 -5.77%

Raymond James Upgrades Columbia Banking To Strong Buy, Raises Target To $31

Raymond James upgraded Columbia Banking System (NASDAQ:COLB) to Strong Buy from Outperform and raised its price target to $31 from $27 following investor meetings.

The firm said management addressed several misconceptions about the bank, including the likelihood of near-term M&A, earnings growth without balance sheet expansion, and the timing of capital return. Analysts said M&A was unlikely in the near term, but earnings growth could still be achieved, and capital return was expected soon.

Raymond James noted that Columbia had returned to its legacy culture and balance sheet following its rebranding, elimination of the executive chairman role, and ongoing balance sheet adjustments. With pro forma profitability projected at 18.6% ROATCE and 1.37% ROAA in 2026, a well-covered 5.4% dividend yield, and the likelihood of a buyback later this year, analysts said the risk-reward profile appeared highly favorable.

Published on: September 15, 2025